Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
Noriday 350 microgram tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, flat, circular, bevel-edged tablet inscribed ‘SEARLE’ on one side and ‘NY’ on the other side. |
Each tablet contains 350 micrograms norethisterone.
Excipient(s) with known effect: Each tablet contains 62.25 mg lactose (as monohydrate).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Norethisterone |
Norethisterone has progestational actions similar to those of progesterone, but is a more potent inhibitor of ovulation and has weak oestrogenic and androgenic properties. It is used to treat a number of disorders of the menstrual cycle. |
| List of Excipients |
|---|
|
Maize starch |
Noriday tablets are supplied in pvc/foil blister packs of 28 and 84 tablets.
Blister packaging consists of 250 micron PVC and 20 micron aluminium foil.
Not all pack sizes may be marketed.
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
PL 00057/1019
26th July 2002
| Drug | Countries | |
|---|---|---|
| NORIDAY | Australia, Ireland, New Zealand, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
